CRMT
America's Car-Mart, Inc.
There isn't enough reported data to score CRMT yet.
TSLA
Tesla, Inc.
TSLA's fundamentals are mixed, but it looks expensive: trading at 437x earnings, more than twice its usual 175x. Analysts expect earnings growth, though they disagree widely on how much.
CRMT Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Healthy | |
| Strong |
CRMT's cash flow and balance sheet are currently healthy, but its revenue and profitability are weak.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
CRMT PE Valuation
CRMT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 1.1x next year's earnings.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
CRMT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CRMT to return to profit, with revenue declining.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
CRMT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | — |
| Q3 2026 | -$24.38 | -1462% |
| Q2 2026 | -$16.79 | -821% |
| Q1 2026 | -$11.15 | -1312% |
| Q4 2025 | -$1.53 | -$0.74 |
| Q3 2025 | $1.79 | +$7.49 |
| Q2 2025 | $2.33 | +$7.25 |
| Q1 2025 | $0.92 | +$5.60 |
| Q4 2024 | -$0.79 | +$2.32 |
CRMT has swung to a loss: it lost $24.38 per share over the past year, after a profit the year before.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA has the edge over CRMT on earnings quality, reporting a profit while its opponent remains loss making.
CRMT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $145.8M | -57% |
| Q2 2026 | $302.8M | -18% |
| Q1 2026 | $286.8M | -12% |
| Q4 2025 | $350.2M | +0.8% |
| Q3 2025 | $341.3M | -1.9% |
| Q2 2025 | $370.2M | +1.5% |
| Q1 2025 | $325.7M | +8.7% |
| Q4 2024 | $347.3M | -4% |
CRMT's revenue has slid since its 2023 peak: $146M last quarter, down 57% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -47% | -45 points |
| Q2 2026 | -12% | -15 points |
| Q1 2026 | -13% | -14 points |
| Q4 2025 | -7.8% | -9.9 points |
| Q3 2025 | -2.2% | -1.8 points |
| Q2 2025 | 3.4% | +3.2 points |
| Q1 2025 | 1.4% | +4.8 points |
| Q4 2024 | 2% | +12 points |
CRMT's operating margin was −47% last quarter, down 45 points from the same quarter a year ago, near the bottom of its range since 2019.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA has the edge over CRMT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA has the edge over CRMT on profitability, with a higher operating margin.
CRMT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $80M | +$86.4M |
| Q2 2026 | $67.4M | +266% |
| Q1 2026 | -$6.2M | +$25.3M |
| Q4 2025 | $8.3M | +$31.9M |
| Q3 2025 | -$6.4M | +$9.6M |
| Q2 2025 | $18.4M | +$30.4M |
| Q1 2025 | -$31.5M | -408% |
| Q4 2024 | -$23.6M | +$7.9M |
CRMT has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
CRMT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +40.2K shares |
| 1 year | +0.7% | +55.5K shares |
| 3 years | +26% | +1.7M shares |
| 5 years | +19% | +1.3M shares |
| Available history | +20% | +1.4M shares |
CRMT has 8M diluted shares, up 0.7% from a year ago, despite $255,000 in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25,000 |
| Q2 2026 | $2,000 |
| Q1 2026 | $23,000 |
| Q4 2025 | $205,000 |
| Q3 2025 | $71,000 |
| Q2 2025 | $2,000 |
| Q1 2025 | $20,000 |
| Q4 2024 | $388,000 |
CRMT spent $255,000 buying back its own shares over the past year, down 47% from the year before.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has the edge over CRMT on shareholder dilution, with a more favorable share count trend.
CRMT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -2.3x | Net Cash |
| Q3 2023 | -0.3x | Net Cash |
| Q2 2023 | 5.1x | High |
| Q4 2022 | 3.5x | Elevated |
| Q3 2022 | 1.7x | Healthy |
CRMT has more cash than debt.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has more cash than debt.
CRMT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.1 | Oversold |
| Stochastic | 18.7 | Oversold |
CRMT's weekly RSI is 28 (oversold) and its Stochastic is 19 (oversold).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
CRMT PE vs Consumer Cyclical Sector
| Metric | CRMT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CRMT has no meaningful PE right now: it lost money over the past year.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
CRMT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.09 | 15% below |
| 20 week MA | $2.09 | 56% below |
| 50 week MA | $11.0 | 92% below |
| 100 week MA | $27.0 | 97% below |
| 200 week MA | $49.6 | 98% below |
CRMT is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over CRMT on trend strength, trading above more of its moving averages.
CRMT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $108.6 | $110.0 | +1.3% |
| 2021 | $110.0 | $102.8 | -6.5% |
| 2022 | $102.8 | $72.1 | -30% |
| 2023 | $72.1 | $75.8 | +5.1% |
| 2024 | $75.8 | $52.3 | -31% |
| 2025 | $52.3 | $25.9 | -51% |
| 2026 YTD | $25.9 | $0.93 | -96% |
CRMT has finished lower in four of the last six years. It's down 96% so far in 2026.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA has the edge over CRMT on returns for 2026, with the stronger performance.